Disclosure of interest: no E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.03 - EPIDEMIOLOGY & RISK FACTORS P2551 - ESOC25-1989 RISK FACTORS AND PREDICTION MODEL OF RECURRENT STROKE FOR PATIENTS WITH SYMPTOMATIC INTRACRANIAL ARTERIAL STENOSIS AND TREATED WITH MEDICAL THERAPY Yixin Sun 1,2 , Ruofan Li 3 , Eyad Almallouhi 4 , Tao Wang 5 , Jie Wang 5 , Jichang Luo 5 , Colin P Derdeyn 6 , Liqun Jiao 5 1 Department of Neurosurgery, Xuanwu Hospital, Beijing, China, 2 Eight-year-program, Grade 2018, Peking Unversity First Hospital, Beijing, China, 3 Health Science Center, Peking University, Beijing, China, 4 Departments of Neurology and Neurosurgery, Medical University of South Carolina, Charleston, United States, 5 Capital Medical University Xuanwu Hospital, Beijing, China, 6 Departments of Radiology and Neurology, University of Iowa Hospitals and Clinics, Iowa City, United States Background and Aims: Intracranial atherosclerosis is a common cause of stroke, with a high risk of recurrent stroke
weather or carrier issues may cause delays
Boosts Production of Energy
Shooting water directly at the powder causes damage
International longevity expert Luigi Fontana from the University of Sydney told Four Corners there was no human clinical trial evidence that NAD+ had health or anti-aging benefits, nor was he aware of any safety data
1 mL VIAL, 10 mL MULTIPLE DOSE VIAL, 30 mL MULTIPLE DOSE VIAL For Intramuscular or Subcutaneous Use Only Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit
